Dr. Ingmar Gorman is a clinical psychologist who specializes in assisting populations who have had experiences with psychedelics and other psychoactive compounds. He is the Administrative Director of the Psychedelic Education and Continuing Care Program at the Center for Optimal Living, where he leads groups, trainings, and works with individual clients. Additionally, Dr. Gorman has extensive training in treating substance misuse, drawing upon mentorship by Dr. Andrew Tatarsky and Dr. Jen Talley, in Harm Reduction Psychotherapy and Mindfulness based approaches. Dr. Gorman received his PhD in clinical psychology from the New School for Social Research. He completed his internship at Bellevue Hospital Center and is currently an NIH funded postdoctoral fellow at New York University's Behavioral Sciences Training in Drug Abuse Research Program (BST), which is NIDA’s largest and longest-standing training program. Dr. Gorman is also site co-principal investigator and therapist on a Phase 3 clinical trial studying the potential psychotherapeutic utility of MDMA for post-traumatic stress disorder.
Specialties: Integrative Harm Reduction Psychotherapy, Substance Use Treatment, Trauma, Psychedelic Psychotherapy and Integration
Recent Publications & Presentations
Gorman, I. (2015) Drug-Assisted Psychotherapy. In Ingersoll, E. & Rak, C. (2nd Ed..), Psychopharmacology for Mental Health Professionals: An Integrative Approach. Cengage Learning.